(Medical 24 Hours) Keimyung University Daegu Dongsan Hospital, ‘Grade 1’ in tuberculosis adequacy evaluation, etc.

(Health Korea News / Yoo Ji-in) ‘Medical 24 Hours’ is a corner that shows brief news related to the medical field that is often overlooked in the media. It may seem like trivial news, but it could be valuable information to someone, so I’m only summarizing the facts.

◆Keimyung University Daegu Dongsan Hospital, ranked ‘1st grade’ in tuberculosis adequacy evaluation

Keimyung University Daegu Dongsan Hospital (Director Jeong Woo-jin) recently achieved grade 1 in the ‘6th Tuberculosis Adequacy Evaluation’ announced by the Health Insurance Review and Assessment Service. Tuberculosis adequacy evaluation is conducted every year to improve the quality of tuberculosis care and support the establishment of an efficient national tuberculosis control policy. This evaluation was conducted on new tuberculosis patients from 505 medical institutions nationwide from January to June last year.

The evaluation items are four major indicators: ▲ Mycobacterium tuberculosis confirmation test implementation rate ▲ Ordinary susceptibility test implementation rate ▲ Rapid susceptibility test implementation rate ▲ Drug prescription daily rate. Daegu Dongsan Hospital received perfect scores in three of these indicators. The overall score was 96.8 points, earning the first grade with excellent scores that exceeded the average of all medical institutions (94.3 points) and the average of general hospitals (94 points). In addition, based on these results, the company was recognized for its excellence in tuberculosis treatment and was selected as an award recipient for the ‘2025 15th Tuberculosis Prevention Day’ hosted by the Korea Disease Control and Prevention Agency.

◆Initiation of research to find ways to recruit essential medical doctors at Incheon General Hospital

Inha University Hospital announced on the 15th that Professor Kim Yeon-ju of the Department of Prevention and Management has begun research in earnest to find ways to secure specialists in essential medical fields and retain them for a long time at general hospitals in the Incheon region.

This study is a research project for ‘Exploring ways to recruit essential medical doctors at Incheon General Hospital’ promoted by the Incheon Metropolitan City Public Health and Medical Support Group, and Professor Kim is the research director, including Professor Choi Seon-geun (Vice-Director of Inha University Hospital) and Professor Lim Min-kyung (Inha University School of Medicine). He will lead the research together with the Vice Dean for Academic Affairs.

At a launch briefing held on the 8th with Incheon City and Incheon Medical Center officials and researchers in attendance, the background and necessity of the study were discussed, and there was an expectation that this study would provide important evidence for establishing a complete system for local essential medical care in Incheon. collected.

Starting with this launch briefing, the research will conduct a review of domestic and international policies and a survey until February, and the situation will be checked through an interim briefing in March. Afterwards, the results will be synthesized and policy recommendations will be made until May, and the final reporting meeting and report submission period has been tentatively confirmed as May.

◆National Cancer Center holds an opening ceremony for an advanced cell processing room for next-generation cancer treatment

The National Cancer Center (Director Yang Han-kwang) held an opening ceremony for the ‘National Cancer Center Advanced Cell Processing Room’ on the first basement floor of the affiliated hospital at 12:00 on Wednesday, January 15th.

The ‘National Cancer Center Advanced Cell Processing Room’ is a facility necessary to process raw materials for CAR-T cell therapy, which is attracting attention as a next-generation treatment, and supply it to pharmaceutical companies. It also provides prescriptions for CAR-T cell therapy to patients in dire need of new treatments. It will be implemented.

CAR-T cell therapy is a type of advanced biopharmaceutical that involves collecting the patient’s own cells, strengthening them through genetic manipulation, and then administering them back to the patient. Because it exerts anti-cancer effects through a completely different mechanism from existing anti-cancer treatments, it is established as a new treatment method that is distinct from surgery, radiation therapy, and anti-cancer drugs.

CAR-T cell therapy introduced in Korea includes Kymriah (Tisagenlecleucel), and health insurance coverage applies to some blood cancers such as diffuse large B-cell lymphoma and B-cell acute lymphoblastic leukemia.

◆Professor Kim Jang-hoon of Korea University Hospital received the Excellence Award from the Korean Society of Neurological and Critical Care Medicine.

Professor Kim Jang-hoon of Neurosurgery at Korea University Anam Hospital
Professor Kim Jang-hoon of Neurosurgery at Korea University Anam Hospital

Professor Jang-Hoon Kim of the Department of Neurosurgery at Korea University Anam Hospital won the Excellence Award at the 15th Annual Academic Conference of the Korean Society of Neurological and Critical Care Medicine in 2024.

Professor Jang-Hoon Kim received this award for his research on the recovery of patients with severe traumatic brain injury, ‘Successful Recovery in a Severe TBI Patient Following Delayed Decompression during Slow Rewatming under Targeted Temperature Management: A Case Report and Literature Review’. Done.

This study is the result of the rapid response of the Severe Trauma Treatment Center at Korea University Anam Hospital. A high school patient who suffered a moderate head injury and was in a coma at the time of admission received appropriate treatment thanks to the quick treatment of the trauma emergency care system. In this process, Professor Jang-Hoon Kim received great attention by introducing the latest treatments, such as hypothermia treatment and intracranial pressure monitoring devices for critically ill neurological patients, and announcing research and clinical results on them.

◆Ilsan Paik Hospital introduces the latest MRI ‘GE Signa Hero 3T’

Inje University Ilsan Paik Hospital (Director Seong-soon Lee) introduced GE SIGNA Hero 3T, a state-of-the-art 3T MRI, and began full-scale operation on January 13th.

The newly introduced Signa Hero is a model equipped with AI deep learning technology, AIR Recon DL, and provides faster and clearer images than existing MRIs. Inspection time can be reduced by up to 60% compared to existing models, and resolution has been improved by about two times. This technology can be applied to both 2D and 3D images.

The blanket-type AIR Coils are made of light and soft material, reducing patient discomfort by reducing the weight felt during MRI examinations. This allows patients with limited movement or physical discomfort to undergo the examination more comfortably.

This equipment provides high-resolution, precise images that enable faster and more precise diagnosis for patients with neurological diseases such as stroke or dementia. In the case of patients with spinal diseases, motion can be corrected during filming along with high-resolution imaging, which can reduce unnecessary re-filming and shorten examination time.

◆Konkuk University Hospital, practicing love for the community by delivering rice of love

Konkuk University Hospital delivered rice of love to the Gwangjin-gu Office on the 13th for the socially underprivileged in the region.

Konkuk University Hospital will provide 500 bags to Gwangjin-gu, 250 bags each to Seongdong-gu and Jungnang-gu, and 1,000 bags of 10kg Konkuk rice. Through this support, Konkuk University Hospital plans to contribute to stabilizing the dietary habits and maintaining health of residents experiencing economic difficulties and to fulfill the hospital’s social responsibility to be considerate of the socially disadvantaged.

Konkuk University Hospital, together with Gwangjin-gu Office, has donated a total of 4,730 bags of rice through the Rice of Love support project since 2006, and is continuing various social contribution activities such as supporting medical expenses for low-income residents of Gwangjin-gu and supporting shingles vaccination expenses.

◆ Professor Jang Hee-jun, Department of Gastroenterology, Boramae Hospital, received the ‘Hamchun Young Medical Scholar Award’ at the Seoul Medical University Alumni Association academic awards ceremony.

Professor Jang Hee-jun, Department of Gastroenterology, Boramae Hospital
Professor Jang Hee-jun, Department of Gastroenterology, Boramae Hospital

Professor Jang Hee-jun of the Department of Gastroenterology at Seoul National University Boramae Hospital (Director Lee Jae-hyeop), operated by Seoul National University Hospital, attended the ‘Hamchun Academic Award/Jang Ki-ryeo Intention Award Ceremony’ held at the ‘2024 Hamchun Year-end Night’ held at the Lotte Hotel in Sogong-dong on Tuesday, December 17 last year. He won the ‘Hamchun Young Medical Scholar Award’.

About 250 alumni from within and outside of Seoul National University College of Medicine attended the event, strengthening the unity of alumni members and encouraging alumni professors’ research motivation by awarding the ‘Hamchun Academic Award’ and the ‘Jang Gi-ryeo Intention Award’.

The ‘Hamchun Young Medical Scientist Award’, won by Professor Heejun Jang, is an award given to a young medical scientist who has contributed to the development of medicine through excellent research achievements and has enhanced the reputation of Seoul Medical University.

Professor Heejun Jang is credited with presenting new possibilities for liver cancer treatment through research that effectively increased the activity of immune cells that kill hepatocellular carcinoma without affecting liver function through the combined use of immune checkpoint inhibitors, targeted therapies, and oral hypoglycemic agents. He received the award in recognition.

◆Korea University Graduate School of Public Health recruits members for the second term of the ‘Future Medical Leadership Forum’ top-level course

Korea University Graduate School of Public Health (Director Seokjun Yoon) announced that it is recruiting members for the second term of the Future Medical Leadership Forum, a top-level course. This course was designed to explore future medical vision and strategies in a rapidly changing health care environment and to cultivate the insight and capabilities essential for leaders in the health care field.

The Future Medical Leadership Forum is a curriculum that covers in-depth key trends and innovative technologies and strategies in the medical industry, such as digital healthcare, bio industry, artificial intelligence (AI) medical technology, and medical policy. In particular, we provide members with insight and knowledge that can be applied in the field through lectures and case analysis by experts with extensive practical experience.

This curriculum will run for 15 weeks from March 11 to June 24, 2025, and will be held every Tuesday at the Lecture Hall on the 9th floor of the Goyeong Campus of Korea University Medical Center.

◆Professor Kim Dong-young of Seoul National University Hospital inaugurated as president of the Korean Society of Rhinology

Professor Kim Dong-young, Department of Otolaryngology, Seoul National University Hospital
Professor Kim Dong-young, Department of Otolaryngology, Seoul National University Hospital

Professor Kim Dong-young of the Department of Otolaryngology at Seoul National University Hospital was inaugurated as the 14th president of the Korean Rhinological Society. The term of office is two years from January 1, 2025.

The Korean Rhinologic Society (KRS) was founded in 1990 and has established itself as Korea’s leading academic organization that promotes the development and research of rhinology (the field of diseases and treatments related to the nose) and encourages academic exchange among members. Professor Kim is an expert with a long career in the field of otolaryngology, and has demonstrated academic leadership in the field of rhinology by holding several important positions, including academic director and training director of the Korean Society of Otolaryngology and general affairs director of the Korean Society of Rhinology.

In his inauguration speech, Professor Kim continued the tradition of the Korean Rhinological Society and presented a clear vision and plan for the development of the society. He valued harmony and communication among members and proposed ‘KRS (Knowledge, Respect, Synergy)’ as the society’s new motto. Through this, they announced that they will create a culture of mutual respect and cooperation beyond academic exchange.

Copyright © Health Korea News Unauthorized reproduction and redistribution prohibited

Source: www.hkn24.com